Mirum Pharmaceuticals, Inc.
MIRM
$67.72
-$2.37-3.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 375.55M | 304.55M | 277.67M | 280.32M | 284.45M |
| Total Receivables | 107.13M | 106.84M | 95.85M | 78.29M | 68.53M |
| Inventory | 24.02M | 22.94M | 22.42M | 22.40M | 21.59M |
| Prepaid Expenses | 23.87M | 19.07M | 14.87M | 11.78M | 12.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 530.58M | 453.40M | 410.82M | 392.79M | 386.63M |
|
|
|||||
| Total Current Assets | 530.58M | 453.40M | 410.82M | 392.79M | 386.63M |
| Net Property, Plant & Equipment | 9.78M | 10.12M | 8.77M | 9.81M | 10.35M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 231.90M | 237.87M | 243.85M | 249.82M | 255.79M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.40M | 7.32M | 5.90M | 5.81M | 5.81M |
| Total Assets | 785.12M | 725.83M | 690.25M | 670.75M | 667.89M |
|
|
|||||
| Total Accounts Payable | 12.17M | 17.66M | 11.64M | 14.62M | 9.55M |
| Total Accrued Expenses | 87.89M | 72.18M | 64.07M | 72.86M | 64.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.04M | 2.08M | 1.64M | 1.71M | 1.51M |
| Total Finance Division Other Current Liabilities | 58.26M | 52.88M | 50.22M | 37.36M | 40.59M |
| Total Other Current Liabilities | 58.26M | 52.88M | 50.22M | 37.36M | 40.59M |
| Total Current Liabilities | 160.36M | 144.80M | 127.58M | 126.55M | 115.75M |
|
|
|||||
| Total Current Liabilities | 160.36M | 144.80M | 127.58M | 126.55M | 115.75M |
| Long-Term Debt | 309.37M | 308.93M | 308.51M | 308.08M | 307.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.36M | 7.88M | 7.00M | 7.97M | 8.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.98M | 9.05M | 13.90M | 2.51M | 3.97M |
| Total Liabilities | 493.07M | 470.67M | 456.99M | 445.11M | 435.87M |
|
|
|||||
| Common Stock & APIC | 953.82M | 919.53M | 892.37M | 870.19M | 851.50M |
| Retained Earnings | -661.81M | -664.72M | -658.86M | -644.18M | -620.39M |
| Treasury Stock & Other | 37.00K | 352.00K | -258.00K | -373.00K | 920.00K |
| Total Common Equity | 292.05M | 255.16M | 233.26M | 225.64M | 232.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 292.05M | 255.16M | 233.26M | 225.64M | 232.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 292.05M | 255.16M | 233.26M | 225.64M | 232.02M |
|
|
|||||